Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
Table 1
Comparison of 18F-FSPG, 18F-FET and 18F-FDG uptake in rat GS9L brain tumors, healthy brain and blood at approximately 1 hr post injection.
The tracer uptake was measured ex vivo and is shown as % ID/g values with standard deviation and ranges. Tumor-to-normal brain (T/brain) and tumor-to-blood ratios (T/blood) were derived from the respective mean values.